Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The Hospital Acquired Disease Testing Market is predicted to reach US$ by 2030 from US$ 3.67 billion in 2021, and to grow at a CAGR of 7.7% between the forecast period 2022 to 2030.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2021. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
By Product (Instruments, Reagents and Consumables) by Test Type (Molecular Diagnostics, Immunoassay, and Others), By Application (Disease Testing, and Drug-Resistance Testing), By Infection Type (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infections), By End User (Hospital, Standalone Laboratories, and Others)
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
Abbott Laboratories, Bayer AG, Becton Dickinson & Company, Danaher Corporation, Sotera Health Company, Ecolab, Hologic, Johnson & Johnson Pvt. Ltd., Getinge AB, Merck Kgaa, Pfizer Inc, Advanced Sterilization Products (ASP), Steris PLC, Pal International, Continental Equipment Company, BGS Beta-Gamma-Service GmbH & Co. KG, C.B.M. S.r.l., Continental Equipment Company, Medizintechnik GmbH & Co. KG, and Reckitt Benckiser
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2030
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Hospital Acquired Disease Testing - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Hospital Acquired Disease Testing - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Hospital Acquired Disease Testing - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Hospital Acquired Disease Testing - ANALYSIS & FORECAST, BY REGION
North America Hospital Acquired Disease Testing
1. North America Hospital Acquired Disease Testing , by Country
1. US
2. Canada
1. North America Hospital Acquired Disease Testing , by Product
2. North America Hospital Acquired Disease Testing , by Type
3. North America Hospital Acquired Disease Testing , by Gender
4. North America Hospital Acquired Disease Testing , by Sales Channel
3. Europe Hospital Acquired Disease Testing
1. Europe Hospital Acquired Disease Testing , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Hospital Acquired Disease Testing , by Product
3. Europe Hospital Acquired Disease Testing , by Type
4. Europe Hospital Acquired Disease Testing , by Gender
5. Europe Hospital Acquired Disease Testing , by Sales Channel
4. Asia Pacific Hospital Acquired Disease Testing
1. Asia Pacific Hospital Acquired Disease Testing , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Hospital Acquired Disease Testing , by product
3. Asia Pacific Hospital Acquired Disease Testing , by Type
4. Asia Pacific Hospital Acquired Disease Testing , by Gender
5. Asia Pacific Hospital Acquired Disease Testing , by Sales Channel
5. Rest of the World Hospital Acquired Disease Testing
1. Rest of the World Hospital Acquired Disease Testing , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Hospital Acquired Disease Testing , by Product
3. Rest of the World Hospital Acquired Disease Testing , by Type
4. Rest of the World Hospital Acquired Disease Testing , by Gender
5. Rest of the World Hospital Acquired Disease Testing , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 82
| Price : US$ 3,500 |
Date : Nov 2024 |
| Category : Electronics |
Pages : 148 |
| Price : US$ 3,500 |
Date : Oct 2024 |
| Category : Services |
Pages : 174 |
Request Sample 
Request Discount 
Inquire Before Buy
